Evolve Biologics is a new kind of biologics company. We’re built around a next-generation technology for bringing critical therapeutics to the people who need them. We believe our patented next-generation technology, PlasmaCap EBA™, is the first major advancement in the field since the 1940s. We believe it will help us deliver critical plasma-derived therapeutics at higher levels of purity, efficiency, and quality than conventional methods can.